Free Trial

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$8.77
+0.03 (+0.34%)
(As of 09/6/2024 ET)
Today's Range
$8.63
$9.05
50-Day Range
$8.65
$12.16
52-Week Range
$8.46
$27.05
Volume
22.95 million shs
Average Volume
16.04 million shs
Market Capitalization
$7.57 billion
P/E Ratio
N/A
Dividend Yield
11.40%
Price Target
$15.19

Walgreens Boots Alliance MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.87 Rating Score
Upside/​Downside
73.2% Upside
$15.19 Price Target
Short Interest
Bearish
10.11% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
0.02mentions of Walgreens Boots Alliance in the last 14 days
Based on 49 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-32.06%
From $2.87 to $1.95 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.64 out of 5 stars

Retail/Wholesale Sector

24th out of 194 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 4 stocks

WBA stock logo

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

WBA Stock Price History

WBA Stock News Headlines

A sign hangs on the front door of Kingdom Trails in Burke, Vt
Weeks after floods, Vermont businesses struggling to get visitors to return
Two bouts of flooding in July has hampered businesses and destinations in an economically depressed section of northeastern Vermont, with some still closed as they continue to repair damage and others urging visitors, who were deterred by the weather, to make the trip
A grocery bag under the door of the house.Food delivery to the door in craft bags. Delivery of groceries home
Instacart Stock Gains Momentum with Profits and AI-Powered Carts (WBA)
Online grocery marketplace and delivery service company Maplebear Inc. (NASDAQ: CART) operates as Instacart. Instacart has had over 25 million customers
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Walgreens Boots Alliance (NASDAQ:WBA) Shares Down 0.6% on Analyst Downgrade
The solution to fast food’s wage hike crisis
Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.
Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $7.50
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/20/2024
Dividend Payable
6/12/2024
Last Earnings
6/27/2024
Ex-Dividend for 9/12 Dividend
8/21/2024
Today
9/07/2024
Dividend Payable
9/12/2024
Next Earnings (Estimated)
10/10/2024
Fiscal Year End
8/31/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
331,000
Year Founded
2014

Price Target and Rating

Average Stock Price Target
$15.19
High Stock Price Target
$25.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+73.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.87
Research Coverage
15 Analysts

Profitability

Net Income
$-3,080,000,000.00
Pretax Margin
-9.34%

Debt

Sales & Book Value

Annual Sales
$139.08 billion
Cash Flow
$6.69 per share
Book Value
$32.78 per share

Miscellaneous

Free Float
713,065,000
Market Cap
$7.57 billion
Optionable
Optionable
Beta
0.70

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Should I Buy Walgreens Boots Alliance Stock? WBA Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Walgreens Boots Alliance, Inc.:

  • Walgreens Boots Alliance stock is currently trading at a low price of $10.92, which may present a buying opportunity for investors looking for undervalued stocks.
  • Despite recent challenges, Walgreens Boots Alliance has a positive return on equity of 12.63%, indicating the company's ability to generate profit from shareholders' equity.
  • Walgreens Boots Alliance recently announced a quarterly dividend of $0.25 per share, offering investors a dividend yield of 9.16%, which can be attractive for income-focused investors.
  • The company's revenue for the last quarter was up 2.8% year-over-year, showing potential growth in its business operations.
  • Analysts forecast that Walgreens Boots Alliance will post earnings per share of 2.87 for the current fiscal year, suggesting potential profitability in the near future.

Cons

Investors should be bearish about investing in Walgreens Boots Alliance, Inc. for these reasons:

  • Walgreens Boots Alliance has faced price target reductions from various analysts, indicating concerns about the company's performance and future prospects.
  • The stock has a negative net margin of -3.99%, which may raise doubts about the company's profitability and operational efficiency.
  • With a debt-to-equity ratio of 0.49, Walgreens Boots Alliance carries a moderate level of debt, which could pose risks in times of economic uncertainty or market downturns.
  • Several research analysts have issued sell ratings on the stock, reflecting a lack of confidence in the company's ability to deliver strong returns to investors.
  • The average rating for Walgreens Boots Alliance is "Hold" with a consensus target price of $16.86, suggesting limited upside potential according to market expectations.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, August 21, 2024. Please send any questions or comments about these Walgreens Boots Alliance pros and cons to contact@marketbeat.com.

WBA Stock Analysis - Frequently Asked Questions

How have WBA shares performed this year?

Walgreens Boots Alliance's stock was trading at $26.11 on January 1st, 2024. Since then, WBA shares have decreased by 66.4% and is now trading at $8.77.
View the best growth stocks for 2024 here
.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) posted its quarterly earnings data on Thursday, June, 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by $0.05. The business's revenue for the quarter was up 2.8% on a year-over-year basis.
Read the conference call transcript
.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does Walgreens Boots Alliance have any subsidiaries?

Walgreens Boots Alliance subsidiaries include Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and others.

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's top institutional shareholders include Thompson Siegel & Walmsley LLC (0.70%), Bank of New York Mellon Corp (0.62%), Susquehanna International Group LLP and LSV Asset Management (0.43%). Insiders that own company stock include Walgreens Boots Alliance, Inc, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO) and AbbVie (ABBV).

This page (NASDAQ:WBA) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners